modelH02AB04_1
Extends from Pharmacokinetic.Models.PK_1C_enteral.
Information
| name: | Methylprednisolone_1 | |
| ATC code: | H02AB04_1 | route: | oral |
| compartments: | 1 | |
| dosage: | 24 | mg |
| volume of distribution: | 1.38 | L |
| clearance: | 0.178 | L/h/kg |
| other parameters in model implementation | ||
Methylprednisolone is a synthetic glucocorticoid corticosteroid drug with potent anti-inflammatory and immunosuppressive properties. It is widely used to treat conditions such as allergic reactions, autoimmune diseases, certain types of arthritis, and is also employed in transplant rejection prophylaxis. It is approved and commonly used in clinical practice today.
Pharmacokinetics
Pharmacokinetic parameters after single oral dose in healthy adult male volunteers.
References
Wang, DD, et al., & Li, ZP (2018). Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. Journal of clinical pharmacy and therapeutics 43(4) 476–483. DOI:10.1111/jcpt.12707 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29766530
Tornatore, KM, et al., & Venuto, RC (1995). Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. Transplantation 59(5) 729–736. DOI:10.1097/00007890-199503150-00016 PUBMED:https://pubmed.ncbi.nlm.nih.gov/7886801
Mehta, J, et al., & Kaushik, NK (2022). Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review. Frontiers in microbiology 13 813358–None. DOI:10.3389/fmicb.2022.813358 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35242118
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.9 | Volume of distribution (L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 0.8 | bioavailiability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 20 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1000 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Pharmacolibrary.Types.TransferRate | ka (from PK_1C_enteral) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_1C_enteral) | 600 | delay between oral administration and absorption (default 10min) |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | elimination half-life |
Revisions
- 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)